Skip to main content
Premium Trial:

Request an Annual Quote

Court Deals Blow to Universities' Patenting Potential

The federal appeals court that handles patent cases has dealt a blow to universities hoping to patent basic research undertaken by their academics, according to a story in The Chronicle of Higher Education. And the court, says The Chronicle's Goldie Blumenstyk, knew exactly what it was doing. In their 9-2 decision, the judges said that patents should be awarded for "useful arts" — inventions with a practical use — not for academic theories, "no matter how groundbreaking or necessary to the later patentable inventions of others." This ruling, says Blumenstyk, came out of a 2002 case involving the validity of a patent on a technique for the identification of how a messenger protein regulates cell function. On the day the patent was awarded, the three grantee institutions and Ariad Pharmaceuticals — which held exclusive rights to commercialize the invention — sued Eli Lilly. They claimed two of Lilly's drugs — Evista and Xigris — infringed the patent. Lilly was ordered to pay $62.5 million in damages, but appealed and said the patent was invalid because it "failed to adequately demonstrate how to actually make the new technique." And the appeals have now gone Lilly's way. According to Blumenstyk, the judges said that universities may not have the resources to work out the practical applications of the research they do, and that might mean they are "disadvantaged" when seeking patents. But, they added, that's the intention of the law.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.